Paakinaho Ville, Makkonen Harri, Jääskeläinen Tiina, Palvimo Jorma J
Institute of Biomedicine/Medical Biochemistry, University of Kuopio, P.O. Box 1627, FI-70211 Kuopio, Finland.
Mol Endocrinol. 2010 Mar;24(3):511-25. doi: 10.1210/me.2009-0443. Epub 2010 Jan 21.
Recent studies have identified FKBP51 (FK506-binding protein 51) as a sensitive biomarker of corticosteroid responsiveness in vivo. In this work, we have elucidated the molecular mechanisms underlying the induction of FKBP51 by the glucocorticoid receptor (GR) in human A549 lung cancer cells showing robust accumulation of FKBP51 mRNA in response to dexamethasone exposure. Our quantitative chromatin immunoprecipitation scans and enhancer activity analyses indicate that activation of the FKBP51 locus by glucocorticoids in vivo is triggered by the loading of GR to enhancers at about 34 kb 5' and about 87 kb 3' of the transcription start site. Interestingly, the region encompassing these enhancers is bordered by CCCTC-binding factor- and cohesin-binding sites. Dexamethasone treatment also decreased the histone density at several regions of the gene, which was paralleled with the occupancy of SWI/SNF chromatin remodeling complexes within the locus. Moreover, silencing of BRM subunit of the SWI/SNF complex blunted the glucocorticoid induction of the locus. The proximal promoter region along with the major intronic enhancer at approximately 87 kb, at which the GR binding peaked, had elevated levels of histone 3 acetylation and H3K4 trimethylation, whereas H3K36 trimethylation more generally marked the gene body and reflected the occupancy of RNA polymerase II. The occurrence of these active chromatin marks within the FKBP51 locus before glucocorticoid exposure suggests that it is poised for transcription in A549 cells. Taken together, these results indicate that the holo-GR is capable of activating transcription and evoking changes in chromatin structure through distant-acting enhancers.
最近的研究已将FKBP51(FK506结合蛋白51)鉴定为体内皮质类固醇反应性的敏感生物标志物。在这项工作中,我们阐明了在人A549肺癌细胞中糖皮质激素受体(GR)诱导FKBP51的分子机制,该细胞在暴露于地塞米松后显示出FKBP51 mRNA的大量积累。我们的定量染色质免疫沉淀扫描和增强子活性分析表明,体内糖皮质激素对FKBP51基因座的激活是由GR加载到转录起始位点约34 kb 5'和约87 kb 3'处的增强子触发的。有趣的是,包含这些增强子的区域以CCCTC结合因子和黏连蛋白结合位点为边界。地塞米松处理还降低了该基因几个区域的组蛋白密度,这与该基因座内SWI/SNF染色质重塑复合物的占据情况平行。此外,SWI/SNF复合物的BRM亚基的沉默减弱了糖皮质激素对该基因座的诱导。近端启动子区域以及约87 kb处的主要内含子增强子(GR结合在此处达到峰值)具有升高的组蛋白3乙酰化和H3K4三甲基化水平,而H3K36三甲基化更普遍地标记基因体并反映RNA聚合酶II的占据情况。在糖皮质激素暴露之前,FKBP51基因座内这些活跃染色质标记的出现表明它在A549细胞中已准备好进行转录。综上所述,这些结果表明全GR能够通过远距离作用的增强子激活转录并引起染色质结构的变化。